Literature DB >> 12810111

Transitional B cells: step by step towards immune competence.

James B Chung1, Michael Silverman, John G Monroe.   

Abstract

Transitional B cells mark the crucial link between bone-marrow (BM) immature and peripheral mature B cells. Examination reveals unexpected heterogeneity, consisting of contiguous subsets with phenotypic and functional differences. Data point to the late transitional B-cell stage as a crucial juncture at which developing B cells gain access to splenic follicles, become responsive to T-cell help and lose sensitivity to negative selection, characterizing the immature B-cell response to B-cell antigen receptor (BCR) signaling in vitro and in vivo. The biological and molecular processes directing maturation through this stage are becoming clearer through biochemical studies and murine models deficient in various components of the BCR signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810111     DOI: 10.1016/s1471-4906(03)00119-4

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  81 in total

1.  Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice.

Authors:  Hans D Brightbill; Surinder Jeet; Zhonghua Lin; Donghong Yan; Meijuan Zhou; Martha Tan; Allen Nguyen; Sherry Yeh; Donnie Delarosa; Steven R Leong; Terence Wong; Yvonne Chen; Mark Ultsch; Elizabeth Luis; Sree Ranjani Ramani; Janet Jackman; Lino Gonzalez; Mark S Dennis; Anan Chuntharapai; Laura DeForge; Y Gloria Meng; Min Xu; Charles Eigenbrot; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Lawren C Wu
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 3.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

4.  T cells are required for the peripheral phase of B-cell maturation.

Authors:  Novica M Milićević; Klaus Nohroudi; Zivana Milićević; Hans-Juergen Hedrich; Jürgen Westermann
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

5.  Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Authors:  Sarah F Andrews; Xuezhi Dai; Byoung Y Ryu; Tod Gulick; Bindu Ramachandran; David J Rawlings
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

Review 6.  A conspicuous role for B cells In Sjögren's syndrome.

Authors:  Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 7.  B lymphocytes: how they develop and function.

Authors:  Tucker W LeBien; Thomas F Tedder
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

8.  BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease.

Authors:  Phillip A Doerfler; Sushrusha Nayak; Roland W Herzog; Laurence Morel; Barry J Byrne
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

9.  Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.

Authors:  R Gill; M J McCabe; A J Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-28       Impact factor: 4.219

10.  Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.

Authors:  Jennie A Hamilton; Qi Wu; PingAr Yang; Bao Luo; Shanrun Liu; Huixian Hong; Jun Li; Mark R Walter; Eleanor N Fish; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2017-09-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.